A Study to Assess Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Chinese Participants Receiving Upadacitinib for Atopic Dermatitis (AD) Through Chart Review
Clinical trial NCT06503536 · COMPLETED
Trial details
- NCT number
- NCT06503536
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-06
- Primary completion
- 2024-10-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.